319 related articles for article (PubMed ID: 33183433)
1. Preparation of Poly[lactic-co-glycolic] Acid Nanospheres and Its Role in Hepatoma Cells.
Shi Z; Li J; Liang H; Hu H; Jiang H
J Nanosci Nanotechnol; 2021 Feb; 21(2):977-986. PubMed ID: 33183433
[TBL] [Abstract][Full Text] [Related]
2. [Effect of PLGA nanoparticles conjugated with anti-OX40/anti-AFP mAbs on cytotoxicity of CTL cells against hepatocellular carcinoma].
Chen M; Ouyang H; Zhou S; Li J; Ye Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Apr; 30(4):337-41. PubMed ID: 24721396
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of superparamagnetic iron oxide/doxorubicin co-loaded poly (lactic-co-glycolic acid) nanospheres prepared by different emulsion solvent evaporation methods.
Mosafer J; Teymouri M
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1146-1155. PubMed ID: 28789586
[TBL] [Abstract][Full Text] [Related]
4. Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer.
Guan X; Gao M; Xu H; Zhang C; Liu H; Lv L; Deng S; Gao D; Tian Y
Drug Deliv; 2016 Nov; 23(9):3307-3318. PubMed ID: 27067032
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Anti-Proliferative Effect of Carboplatin in Ovarian Cancer Cells Exploiting Chitosan-Poly (Lactic Glycolic Acid) Nanoparticles.
Alassaif FR; Alassaif ER; Kaushik AK; Dhanapal J
Recent Pat Nanotechnol; 2023; 17(1):74-82. PubMed ID: 35021983
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib-Loaded PLGA Carriers for Enhanced Drug Delivery and Cellular Uptake in Liver Cancer Cells.
Caputo TM; Cusano AM; Principe S; Cicatiello P; Celetti G; Aliberti A; Micco A; Ruvo M; Tagliamonte M; Ragone C; Minopoli M; Carriero MV; Buonaguro L; Cusano A
Int J Nanomedicine; 2023; 18():4121-4142. PubMed ID: 37525693
[TBL] [Abstract][Full Text] [Related]
7. Decorin-loaded poly lactic-co-glycolic acid nanoparticles modified by anti-alpha fetoprotein antibody: preparation, proliferation inhibition and induced apoptosis effects on HepG2 cells in vitro.
Yang Q; Wang S; Wang Y; Qu Y; Xue J; Mi Y; Wang Y; Luo X; Deng Z; Wang G
J Pharm Pharmacol; 2017 Jun; 69(6):633-641. PubMed ID: 28266029
[TBL] [Abstract][Full Text] [Related]
8. Preparation of copolymer 7-hydroxyethyl chrysin loaded PLGA nanoparticles and the
Wang X; Yang B; Ma C; He L; Jing L; Huang Q; Ma H
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 53(1):116-125. PubMed ID: 38426693
[TBL] [Abstract][Full Text] [Related]
9. Effect of paclitaxel-loaded nanoparticles on the viability of human hepatocellular carcinoma HepG2 cells.
Hou ZH; Zhao WC; Zhang Q; Zheng W
Asian Pac J Cancer Prev; 2015; 16(5):1725-8. PubMed ID: 25773816
[TBL] [Abstract][Full Text] [Related]
10. Poly(lactic-
Kumar P; Singh AK; Raj V; Rai A; Keshari AK; Kumar D; Maity B; Prakash A; Maiti S; Saha S
Int J Nanomedicine; 2018; 13():975-990. PubMed ID: 29497292
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characteristics of DNA-nanoparticles targeting to hepatocarcinoma cells.
He Q; Liu J; Sun X; Zhang ZR
World J Gastroenterol; 2004 Mar; 10(5):660-3. PubMed ID: 14991933
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib-Loaded PLGA-TPGS Nanosystems Enhance Hepatocellular Carcinoma Therapy Through Reversing P-Glycoprotein-Mediated Multidrug Resistance.
Tang M; Huang Y; Liang X; Tao Y; He N; Li Z; Guo J; Gui S
AAPS PharmSciTech; 2022 Apr; 23(5):130. PubMed ID: 35487999
[TBL] [Abstract][Full Text] [Related]
13. Effect of the Emulsion Solvent Evaporation Technique Cosolvent Choice on the Loading Efficiency and Release Profile of Anti-CD47 from PLGA Nanospheres.
Safari H; Felder ML; Kaczorowski N; Eniola-Adefeso O
J Pharm Sci; 2022 Sep; 111(9):2525-2530. PubMed ID: 35447106
[TBL] [Abstract][Full Text] [Related]
14. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method.
Kashi TS; Eskandarion S; Esfandyari-Manesh M; Marashi SM; Samadi N; Fatemi SM; Atyabi F; Eshraghi S; Dinarvand R
Int J Nanomedicine; 2012; 7():221-34. PubMed ID: 22275837
[TBL] [Abstract][Full Text] [Related]
15. Development of PLGA-based itraconazole injectable nanospheres for sustained release.
Bian X; Liang S; John J; Hsiao CH; Wei X; Liang D; Xie H
Int J Nanomedicine; 2013; 8():4521-31. PubMed ID: 24311942
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
Ravi Kumar MN; Bakowsky U; Lehr CM
Biomaterials; 2004 May; 25(10):1771-7. PubMed ID: 14738840
[TBL] [Abstract][Full Text] [Related]
17. In vitro degradation of poly (D, L-lactide-co-glycolide) nanoparticles loaded with linamarin.
Hussein AS; Abdullah N; Ahmadun FR
IET Nanobiotechnol; 2013 Jun; 7(2):33-41. PubMed ID: 24046903
[TBL] [Abstract][Full Text] [Related]
18. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.
Li Y; Pei Y; Zhang X; Gu Z; Zhou Z; Yuan W; Zhou J; Zhu J; Gao X
J Control Release; 2001 Apr; 71(2):203-11. PubMed ID: 11274752
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor activity in A431 cells via encapsulation of 20(R)-ginsenoside Rg3 in PLGA nanoparticles.
Zhang S; Liu J; Ge B; Du M; Fu L; Fu Y; Yan Q
Drug Dev Ind Pharm; 2017 Oct; 43(10):1734-1741. PubMed ID: 28581836
[TBL] [Abstract][Full Text] [Related]
20. Distinct endocytosis and immune activation of poly(lactic-co-glycolic) acid nanoparticles prepared by single- and double-emulsion evaporation.
Pusch L; Brox R; Scheuer K; Yokosawa T; Wu M; Zubiri BA; Spiecker E; Jandt KD; Fischer D; Hackstein H
Nanomedicine (Lond); 2021 Oct; 16(23):2075-2094. PubMed ID: 34523349
[No Abstract] [Full Text] [Related]
[Next] [New Search]
